IBIS: identify biomarker-based subgroups with a Bayesian enrichment design for targeted combination therapy (BMC Medical Research Methodology) |
20 march 2023 20:32:23 |
IBIS: identify biomarker-based subgroups with a Bayesian enrichment design for targeted combination therapy (BMC Medical Research Methodology) |
Combination therapies directed at multiple targets have potentially improved treatment effects for cancer patients. Compared to monotherapy, targeted combination therapy leads to an increasing number of subgro... Tweet |
88 viewsCategory: Medicine |
blog comments powered by Disqus |
Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice. |